Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

Virologic characteristics of subclinical and symptomatic genital herpes infections.

Wald A, Zeh J, Selke S, Ashley RL, Corey L.

N Engl J Med. 1995 Sep 21;333(12):770-5.

2.

Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.

Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, Krieger JN, Corey L.

N Engl J Med. 2000 Mar 23;342(12):844-50.

3.

Genital shedding of herpes simplex virus among men.

Wald A, Zeh J, Selke S, Warren T, Ashley R, Corey L.

J Infect Dis. 2002 Oct 15;186 Suppl 1:S34-9.

PMID:
12353185
4.

Recurrence rates in genital herpes after symptomatic first-episode infection.

Benedetti J, Corey L, Ashley R.

Ann Intern Med. 1994 Dec 1;121(11):847-54.

PMID:
7978697
5.

Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors.

Krone MR, Wald A, Tabet SR, Paradise M, Corey L, Celum CL.

Clin Infect Dis. 2000 Feb;30(2):261-7.

PMID:
10671325
6.

Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.

Wald A, Zeh J, Barnum G, Davis LG, Corey L.

Ann Intern Med. 1996 Jan 1;124(1 Pt 1):8-15.

PMID:
7503497
7.

Underdiagnosis of genital herpes by current clinical and viral-isolation procedures.

Koutsky LA, Stevens CE, Holmes KK, Ashley RL, Kiviat NB, Critchlow CW, Corey L.

N Engl J Med. 1992 Jun 4;326(23):1533-9.

8.

Reducing the risk of transmitting genital herpes: advances in understanding and therapy.

Leone P.

Curr Med Res Opin. 2005 Oct;21(10):1577-82. Review.

PMID:
16238897
9.
10.

Once-daily valacyclovir to reduce the risk of transmission of genital herpes.

Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, Douglas JM Jr, Paavonen J, Morrow RA, Beutner KR, Stratchounsky LS, Mertz G, Keene ON, Watson HA, Tait D, Vargas-Cortes M; Valacyclovir HSV Transmission Study Group.

N Engl J Med. 2004 Jan 1;350(1):11-20.

11.
12.

Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time.

Benedetti JK, Zeh J, Corey L.

Ann Intern Med. 1999 Jul 6;131(1):14-20.

PMID:
10391810
13.

Asymptomatic maternal shedding of herpes simplex virus at the onset of labor: relationship to preterm labor.

Brown ZA, Benedetti J, Selke S, Ashley R, Watts DH, Corey L.

Obstet Gynecol. 1996 Apr;87(4):483-8.

PMID:
8602295
14.

A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group.

Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE.

N Engl J Med. 1999 Nov 4;341(19):1432-8.

15.
16.

Prevalence and determinants of genital shedding of herpes simplex virus among women attending Italian colposcopy clinics.

Boselli F, Chiossi G, Bortolamasi M, Gallinelli A.

Eur J Obstet Gynecol Reprod Biol. 2005 Jan 10;118(1):86-90.

PMID:
15596279
17.

Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization.

Cherpes TL, Melan MA, Kant JA, Cosentino LA, Meyn LA, Hillier SL.

Clin Infect Dis. 2005 May 15;40(10):1422-8. Epub 2005 Mar 29.

PMID:
15844064
18.

Emergence of herpes simplex type 1 as the main cause of recurrent genital ulcerative disease in women in Northern Ireland.

Coyle PV, O'Neill HJ, Wyatt DE, McCaughey C, Quah S, McBride MO.

J Clin Virol. 2003 May;27(1):22-9.

PMID:
12727525
19.

Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor.

Brown ZA, Benedetti J, Ashley R, Burchett S, Selke S, Berry S, Vontver LA, Corey L.

N Engl J Med. 1991 May 2;324(18):1247-52.

20.

Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes.

Frenkel LM, Garratty EM, Shen JP, Wheeler N, Clark O, Bryson YJ.

Ann Intern Med. 1993 Mar 15;118(6):414-8.

PMID:
8439114

Supplemental Content

Support Center